Skip to content
DilutionScan
Exascale Labs Holdings Inc. logo
XLAB$2.13+4.17%

Exascale Labs Holdings Inc.

Sector: Services-Prepackaged SoftwareIndustry: Software - InfrastructureCountry: USExchange: Nasdaq

Mkt Cap$136.71M
Float & O/S
Inst Own

DilutionScan read 25 of Exascale Labs Holdings Inc.'s SEC filings and found 2 warrant series, 1 convertible and 1 S-1 registration on file for XLAB. The latest dilution event on file is a registration statement on Oct 30, 2026. Analysis updated Oct 30, 2026.

Signal8 Summary

XLAB

Fast-growing but deeply unprofitable, dilution-heavy micro-cap

Business
WeakLoss $12.2M vs $14.8M revenue, 16.3% gross margin
Stock risk
HighFresh SPAC, 133.8% potential dilution, $87.5M micro-cap

Snapshot

Exascale Labs is a newly public AI-infrastructure company that just completed a SPAC merger and began Nasdaq trading in August 2026. FY2026 revenue grew 111% to $14.8M, a genuine growth signal, but the net loss widened to $12.2M, close to the entire revenue base, and gross margin is thin at 16.3%.

What's Happening Right Now

  • : On Sep 28, 2026, Exascale reported FY2026 revenue of $14.8M (up 111% YoY), but net loss widened to $12.2M from $7.7M, with gross margin only 16.3% and pre-deal cash of $2.7M plus ~$11.8M in merger proceeds.
  • : Exascale named its post-closing board on Sep 22, 2026, including Nobel laureate David Card as Lead Independent Director, a governance move with no direct financial impact.
  • : Exascale signed a non-binding LOI with Compal Electronics on Sep 14, 2026 to jointly develop an 800 VDC GPU validation platform, with commercial terms still to be finalized.
  • : Exascale and EnergyBank signed a non-binding MOU on Aug 31, 2026 to pair offshore wind power with Exascale's AI compute infrastructure, targeting up to 10MW of compute per turbine.
  • : Exascale Labs completed its business combination with D. Boral ARC Acquisition I Corp. on Aug 27, 2026, beginning Nasdaq trading as XLAB.
  • : Closed an offering. Proceeds are not disclosed in the filings reviewed.
  • : Issued warrants over 14.10M shares across 2 series.
  • : Registered additional securities for sale on Form S-1.

Raise routes on file: pending S-1 · latest dilution event 4 days ago

Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need

AI dilution summary

The dominant contractual driver and its mechanism, then each further driver ranked.

Latest dilution event

Oct 30, 2026 · Registration

How we read filings

Every warrant, convertible, ATM and shelf, cited to the filing

Free to read in full with a free account

$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)

Share count and cash history

Shares outstanding, potential dilution and cash over time

S-1 · 1

What is this?

Size, shares registered and dates with Pro

S-1 · resale registration

Issued 2026

Filed

Proposed maximum

Shares registered

Filed
Effective
Filing link and full terms

Warrants · 2

What is this?

Exercise price, shares and dates with Pro

Warrant

Issued 2025

Outstanding

Shares Underlying

Exercise Price

Outstanding
Type
Anti-Dilution
Cashless Exercise
Expiration
Filing link and full terms

Warrant

Issued 2025

Outstanding

Shares Underlying

Exercise Price

Outstanding
Type
Anti-Dilution
Cashless Exercise
Expiration
Filing link and full terms

Convertibles · 1

What is this?

Principal, conversion terms and dates with Pro

Convertible

Converted

Principal

Conversion Price

Remaining principal
Shares on conversion
Interest rate
Maturity
Filing link and full terms

Know who's about to sell into your XLAB trade

Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.

$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)

DilutionScan ProEvery instrument in full · $59/mo